Response by Schneider et al to Letter Regarding Article, "Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial"
Circ Cardiovasc Interv
.
2018 Jun;11(6):e006699.
doi: 10.1161/CIRCINTERVENTIONS.118.006699.
Authors
Peter A Schneider
1
,
John R Laird
2
,
Gunnar Tepe
3
,
Marianne Brodmann
4
,
Thomas Zeller
5
,
Dierk Scheinert
6
,
Christopher Metzger
7
,
Antonio Micari
8
,
Ravish Sachar
9
,
Michael R Jaff
10
,
Hong Wang
11
,
Melissa S Hasenbank
11
,
Prakash Krishnan
12
;
IN.PACT SFA Trial Investigators
Affiliations
1
Kaiser Foundation Hospital, Hawaii Permanente Medical Group, Honolulu.
2
University of California, Davis, Sacramento.
3
RoMed Klinikum, Rosenheim, Germany.
4
Medical University of Graz, Austria.
5
Universitäts-Herzzentrum Freiburg-Bad Krozingen, Germany.
6
University Hospital Leipzig, Germany.
7
Wellmont Holston Valley Medical Center, Kingsport, TN.
8
GVM Care and Research, Maria Cecilia Hospital, Cotignola, Italy.
9
UNC-REX Health Care, Raleigh, NC.
10
Newton-Wellesley Hospital, Newton, MA.
11
Medtronic, Santa Rosa, CA.
12
Mount Sinai Medical Center, New York, NY.
PMID:
29895603
DOI:
10.1161/CIRCINTERVENTIONS.118.006699
No abstract available
Publication types
Letter
Comment
MeSH terms
Femoral Artery*
Popliteal Artery*